TP53 Mutational Status and Prediction of Benefit from Adjuvant 5-Fluorouracil in Stage III Colon Cancer Patients-Reference-Cited by-同舟云学术

TP53 Mutational Status and Prediction of Benefit from Adjuvant 5-Fluorouracil in Stage III Colon Cancer Patients

Published:2015-08 Issue:8 Volume:2 Page:825-830
ISSN:2352-3964
Container-title:EBioMedicine
language:en
Short-container-title:EBioMedicine

Author:

Kandioler Daniela,Mittlböck Martina,Kappel Sonja,Puhalla Harald,Herbst Friedrich,Langner Cord,Wolf Brigitte,Tschmelitsch Jörg,Schippinger Walter,Steger Günther,Hofbauer Friedrich,Samonigg Hellmut,Gnant Michael,Teleky Bela,Kührer Irene

Publisher

Elsevier BV

Subject

General Biochemistry, Genetics and Molecular Biology,General Medicine

Reference27 articles.

1. The predictive value of p53 and p33(ING1b) in patients with Dukes'C colorectal cancer;Ahmed;Colorectal Dis.,2008

2. Strategy for prevention of cancers of the esophagus;Akiyama;Ann. N. Y. Acad. Sci.,2014

3. Prognostic significance of K-ras and TP53 mutations in the role of adjuvant chemotherapy on survival in patients with Dukes C colon cancer;Bleeker;Dis. Colon Rectum,2001

4. Colorectal cancer;Brenner;Lancet,2014

5. Randomized phase III study of capecitabine plus oxaliplatin compared with fluorouracil/folinic acid plus oxaliplatin as first-line therapy for metastatic colorectal cancer;Cassidy;J. Clin. Oncol.,2008

Cited by 39 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. TP53 mutations in Romanian patients with colorectal cancer;Genes and Environment;2023-07-01

2. Integrating machine learning and single-cell trajectories to analyze T-cell exhaustion to predict prognosis and immunotherapy in colon cancer patients;Frontiers in Immunology;2023-05-03

3. Carbon-Based Nanomaterials as Drug Delivery Agents for Colorectal Cancer: Clinical Preface to Colorectal Cancer Citing Their Markers and Existing Theranostic Approaches;ACS Omega;2023-03-14

4. Review of 5-FU resistance mechanisms in colorectal cancer: clinical significance of attenuated on-target effects;Cancer Drug Resistance;2023

5. Network Pharmacology and Molecular Docking Validation to Reveal the Pharmacological Mechanisms of Kangai Injection against Colorectal Cancer;BioMed Research International;2022-08-21